| |
|
|
Daily Hemodialysis and
the Outcome of Acute Renal Failure
Schiffl H, Lang SM, Fischer R. Daily
hemodialysis and the outcome of acute renal failure. N Engl J Med 2002;
346(5):305-310.
What's the
punchline?
Daily, as opposed to
alternate day, dialysis improves outcomes in critical illness
Verdict:
  1/2
An important contribution to
the critical care literature with some methodological flaws
The
implications of this study are different from what you would expect
looking at the title. Although the patients in the daily dialysis group
were more frequently dialysed, this was less aggressive, in terms of
fluid removal. The implications are:
1. In critical illness, acute renal failure is associated with poor
outcome: the reason is unknown.
2. Critical illness is a catabolic state, with increased production of
toxic by-products of metabolism, which accumulate in renal failure.
3. Daily dialysis is more effective for solute removal than
(conventional) alternate day dialysis.
4. Hemodynamically, critically ill patients do not tolerate aggressive
fluid removal. Patients dialysed daily require less fluid removal pre
session, and this leads to less hypotension.
5. Patients dialysed daily have lower mortality (ARR 18%, NNT
5.5), and significantly lower incidence of infection, respiratory
failure and gi bleeds. It is unclear whether these outcomes relate to
accumulation of toxic metabolites or transient hypotension in the
alternate day dialysis group.
See critical appraisal below
Abstract
Background
Intermittent hemodialysis is
widely used as renal-replacement therapy in patients with
acute renal failure, but an adequate dose has not been
defined. We performed a prospective study to determine the
effect of daily intermittent hemodialysis, as compared with
conventional (alternate-day) intermittent hemodialysis, on
survival among patients with acute renal failure.
Methods
A total of 160 patients with acute renal
failure were assigned to receive daily or conventional
intermittent hemodialysis. Survival was the primary end point
of the study. The duration of acute renal failure and the
frequency of therapy-related complications were secondary end
points.
Results
The two study groups were similar with
respect to age, sex, cause and severity of acute renal
failure, medical or surgical intensive care setting, and the
score on the Acute Physiology, Age, and Chronic Health
Evaluation. Daily hemodialysis resulted in better control of
uremia, fewer hypotensive episodes during hemodialysis, and
more rapid resolution of acute renal failure (mean [±SD], 9±2
vs. 16±6 days; P=0.001) than did conventional hemodialysis.
The mortality rate, according to the intention-to-treat
analysis, was 28 percent for daily dialysis and 46 percent
for alternate-day dialysis (P=0.01). In a multiple regression
analysis, less frequent hemodialysis (on alternate days, as
opposed to daily) was an independent risk factor for death.
Conclusions
The high mortality rate among critically
ill patients with acute renal failure who require
renal-replacement therapy is related to both coexisting
conditions and uremic damage to other organ systems.
Intensive hemodialysis reduces mortality without increasing
hemodynamically induced morbidity.
Critical Appraisal
Question: does daily dialysis improve
outcome in critically ill patients with acute renal failure?
Setting: prospective controlled trial at single institution
(multiple hospitals)
in Germany between January 1993 and September 1998.
Methodology
160
patients with acute renal failure (ARF) requiring dialysis were
alternately
assigned to daily (80) or alternate day (80) intermittent hemodialysis.
Two thirds of these patients were medical, one third surgical. Over 50%
of the patients developed ARF as a consequence of hypotension. There is
no information given about the use of CRRT (continuous renal replacement
therapy) at the institution, leading to the possibility of selection
bias: sicker patients may have received CRRT, and information about
outcomes would have been useful.
The inclusion criteria, and evidence of
renal failure requiring dialysis, were in keeping with standard
practice. We assume that the patients were hemodynamically stable and
suitable for IHD rather than CRRT, although this information is not
given (e.g. how many were being treated with pressors on enrollment
etc). This suggests selection bias: CRRT was available at the
institution, and we do not know if sicker patients were dialysed with
this mode as would be standard practice in European ICUs. Patients were excluded if they had
chronic renal insufficiency, rapidly progressive glomerulonephritis,
interstitial nephritis or post renal obstruction. Two patients with
Goodpasteur's syndrome "sneaked" into the study, and were included in
intention to treat analysis.
Randomization was by alternating order, and
physicians caring for the patients were blinded until after the first
dialysis session.
The dose of hemodialysis was calculated with a urea kinetics model: none
of the patients actually received the prescribed dose.
The primary outcome measure was mortality
at 14 days after last session of dialysis. This is an unusual measure in
critical care: usually (and controversially) it is 28 day mortality. We
are not informed when this day occurred - a mean time with a range would
have been helpful. We are told, however that renal failure resolved in
the treatment group (daily dialysis - TG) at 9 +/- 2 days, and in the
conventional group (alternate day dialysis - AG) at 16 +/-6 days.
Thus it would appear that the endpoint for each group was at
significantly different timescales, and this may have led to bias
(cumulative mortality in critically ill patients will always be higher
at 30 days than at 23 days), and this is a flaw in the study.
Secondary endpoints were: presence or
absence of sepsis, oliguria,& hypotension.
Statistical analysis was performed using
paired t tests and Fisher's exact test.
Results
All
patients were accounted for: six patients were switched to CRRT and six
underwent surgery. Data was analysed on intention to treat basis and
data is presented including and excluding these patients.
Although patients were similar to baseline, daily dialysis was clearly
superior to alternate day dialysis for creatinine clearance.
Interestingly ultrafiltration volume (fluid removal) was lower
(including cumulatively) in the daily dialysis group. Unsurprisingly,
the alternate day removal of 3.5 litres of fluid (as opposed to the
daily removal of 1.2 litres) was associated with significantly more
hypotension (20% absolute increase in risk). The AG also had a
significantly higher incidence of sepis/SIRS (24% absoulute increase),
respiratory failure (34% absolute increase), GI bleeding (15% absolute
increase).
The overall mortality rate was 37%, surprisingly high, 28% in the TG and
46% in the AG. The ARR (absolute risk reduction) was 18% with NNT
(number needed to treat) of 5.5. Alternate day dialysis, sepsis and
higher Apache III scores at randomization were associated with worse
outcomes.
Impression
This
study is a useful contribution to the critical care literature. This
represents clear evidence that alternate day intermittent hemodialysis
with aggressive fluid removal, leads to poor outcomes in critically ill
patients. As to whether daily dialysis, which is associated with better
solute removal, with less aggressive fluid removal, is a magic bullet,
or less harmful is an interesting distinction. The mortality rates
appear high by ICU standards, but are, in fact lower than most published
series. The accompanying editorial cites the preponderance of medical
ICU patients as the reason for lower mortality; medical ICU,
universally, has higher mortality rates than surgical units. The more
likely scenario is that sicker patients were preselected out of the
study e.g. they received CRRT and were not enrolled.
The mortality endpoint is irritating. So what if patients in the AG had
a lower mortality 14 days after end of dialysis? How many of them were
alive at 28 days? How many of them were discharged home? How many of
them were alive at 6 and 12 months? These would be more conventional
mortality endpoints.
What really needs to be studied now is daily dialysis versus continuous
veno-venous hemodiafiltration, which many of us would consider the goal
standard in this patient population.
Overall I have learned three things from this
study:
1. In consult based ICU systems it is essential to discuss dialysis
plans with the nephrologists. Aggressive fluid removal is associated
with worsened outcomes, and dialysis, for the most part should be for
solute removal.
2. Dialysis should be performed more frequently than before, and it is
probably no longer acceptable for patients to be dialysed Friday and
then Monday "because we don't have enough staff at the weekend". This
has enormous resource allocation implications.
3. The hypothesis touted in the CRRT literature about the importance of
hemodynamic instability in critically ill patients undergoing dialysis
is probably correct.
Reviewed by
Patrick Neligan , University of
Pennsylvania, March 2002
|
|
|
|
|